School of Medicine


Showing 101-200 of 260 Results

  • Mary Leonard

    Mary Leonard

    Arline and Pete Harman Professor and Professor of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly Interests My multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.

  • Stephanie A. Leonard

    Stephanie A. Leonard

    Instructor, Obstetrics & Gynecology - Maternal Fetal Medicine

    Current Research and Scholarly Interests The goal of my research is to improve the health of birthing persons, infants, and children, and advance equity in their care and outcomes. My specific interests include perinatal and nutritional epidemiology; maternal and child health and nutrition; health disparities; and applying novel epidemiological methods to perinatal health research

  • Michael Leong

    Michael Leong

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly Interests - Intrathecal / Intraspinal Analgesics
    - Ziconotide (Prialt)
    - Resiniferatoxin
    - Industry-supported clinical trials

  • John Leppert

    John Leppert

    Associate Professor of Urology and, by courtesy, of Medicine (Nephrology) at the Palo Alto Veterans Affairs Health Care System

    Current Research and Scholarly Interests Our research aims to improve the global quality of care for patients with Urologic Cancer with a particular focus on kidney cancer. We are investigating novel proteomic platforms and assays to diagnose kidney cancer and predict response to therapy. We are evaluating the comparative effectiveness of various kidney cancer surgeries and their impact on chronic kidney disease and its downstream effects. We are applying epidemiology, bioinformatics, and health services methods to urologic conditions.

  • Robert Kazimierz Lesniak

    Robert Kazimierz Lesniak

    Instructor, Pathology

    Bio Robert K. Le?niak joined the Medicinal Chemistry Knowledge Center at Stanford ChEM-H in 2018 as a postdoctoral fellow. Prior to coming to Stanford, he worked with Professor Chris Schofield at the University of Oxford, as a postdoctoral research associate, designing novel antibiotics for the European gram-negative antibacterial engine (ENABLE) and UK Medical Research Council (MRC). Dr Le?niak also completed his DPhil under the guidance of Professor Schofield as a BHF-CRE studentship recipient, which involved the design and implementation of small molecules targeting Fe(II), 2-oxoglutarate dependent oxygenase enzymes involved in carnitine biosynthesis and hypoxic response as a means to treat cardiovascular disease. In addition, work on small-molecule modulation of bacterial metallo-beta-lactamases to combat antibiotic resistance was also carried out. Dr Le?niak completed his undergraduate at the University of Bristol, and worked at GlaxoSmithKline, North Carolina, developing inhibitors of bromodomains and histone acetyl-transferases. He is currently working with Professor Thomas Montine at the Stanford School of Medicine on the design of neurotransmitter prodrugs.

  • Ann Leung

    Ann Leung

    Professor of Radiology (Thoracic Imaging) at the Stanford University Medical Center

    Current Research and Scholarly Interests High-resolution computed tomography of the thorax, particularly its application in the setting of acute lung disease in the immunocompromised host; quantitative assessment of abnormalities using thin-section CT; and enhancement characteristics of lung cancers on CT and MRI

  • Lawrence Leung

    Lawrence Leung

    Maureen Lyles D'Ambrogio Professor in the School of Medicine

    Current Research and Scholarly Interests Our long term interest is to have a better understanding of the natural antithrombotic pathways and the pathophysiology of vascular thrombosis. We have focused on thrombin, the key enzyme in the blood clotting cascade.Our goal is to develop new antithrombotic agents and devise new diagnostic tests for vascular thrombotic disorders.

  • Marc Levenston

    Marc Levenston

    Associate Professor of Mechanical Engineering and, by courtesy, of Radiology (Radiological Sciences Laboratory)

    Current Research and Scholarly Interests My lab's research involves the function, degeneration and repair of musculoskeletal soft tissues, with a focus on meniscal fibrocartilage and articular cartilage. We are particularly interested in the complex interactions between biophysical and biochemical cues in controlling cell behavior, the roles of these interactions in degenerative conditions such as osteoarthritis, and development of tissue engineered 3D model systems for studying physical influences on primary and progenitor cells.

  • Craig Levin

    Craig Levin

    Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine) and, by courtesy, of Physics, of Electrical Engineering and of Bioengineering

    Current Research and Scholarly Interests Molecular Imaging Instrumentation
    Laboratory

    Our research interests involve the development of novel instrumentation and software algorithms for in vivo imaging of cellular and molecular signatures of disease in humans and small laboratory animal subjects.

  • Eleanor Levin

    Eleanor Levin

    Clinical Professor, Medicine - Cardiovascular Medicine

    Bio Eleanor Levin completed her undergraduate degree at Stanford, Phi Beta Kappa in Human Biology with Distinction, and her MD at UCSF as a Phi Beta Kappa Scholar. Her first internship was at Children's Hospital of San Francisco in pediatrics and her second at the Cleveland Clinic in internal medicine. She completed internal medicine training at Georgetown University and cardiology fellowship at George Washington University in Washington, D.C. At GW she undertook an advanced fellowship in echocardiography and lipids following her general cardiology fellowship. After fellowship training, Dr. Levin joined the GW faculty as an assistant professor of medicine in the Lipid Research Clinic. Subsequently she joined The Permanente Medical Group in northern California as a non-invasive cardiologist. She directed the Echocardiography Lab at Kaiser Santa Clara and introduced TEE and stress echo during her 25-year tenure. She introduced CT angiography of the heart at Santa Clara and coordinated joint readings between Radiology and Cardiology for 15 years. She created the Cholesterol Management and Heart Failure Programs initially at Santa Clara and eventually at more than 20 medical centers in Northern California. She was Kaiser's regional expert in lipidology as well as in cardiac disease in pregnancy in a patient population of 4 million. Dr. Levin served as Chief of Cardiology at Santa Clara for 16 years and as Chair of the Chiefs of Cardiology (120 cardiologists) for Northern California Kaiser for 8 years. She directed the Regional Cardiac Rehabilitation Program using home-based comprehensive rehabilitation across 18 medical centers for nearly three decades. During this time, she led teams developing cardiac guidelines embedded in order sets and electronic medical records throughout Kaiser medical centers to improve quality. She has spoken about and presented her work on population management and quality improvement nationally and internationally. Her awards include the national NCQA (National Committee of Quality Assurance) Award for Excellence in Cardiac Care, the Exceptional Contribution Award from The Permanente Medical Group for ?exceptional work in care management programs? for heart failure and cholesterol management, the Santa Clara County Medical Association Outstanding Achievement Award for cardiac care management, and the Silicon Business Journal Award as one of the "Top 100 Influential Women in Silicon Valley." She is a fellow of the American College of Cardiology and the American Heart Association. She is board certified in both Internal Medicine and in Cardiovascular Diseases by the American Board of Internal Medicine.
    Dr. Levin is a member of the Preventive Cardiology group. She consults on pregnant patients with heart disease as well as general cardiology patients with lipid disorders and a broad range of cardiovascular diseases.

  • Joshua Levin, MD

    Joshua Levin, MD

    Clinical Assistant Professor, Orthopaedic Surgery

    Bio Dr. Levin completed a residency in physical medicine and rehabilitation at the University of Michigan in 2007, and a pain medicine fellowship at the Virginia Commonwealth University in 2008. Currently, he is a member of both the departments of orthopedic surgery and neurosurgery at Stanford University, where he also is the director of the PM&R interventional spine fellowship and the interim director of the PM&R residency program.

  • Douglas F. Levinson, M.D.

    Douglas F. Levinson, M.D.

    Walter E. Nichols, M.D. Professor in the School of Medicine, Emeritus

    Current Research and Scholarly Interests Dr. Levinson directs the Program on the Genetics of Brain Function in the Department of Psychiatry and Behavioral Sciences. The program investigates the genetic basis of psychiatric disorders (schizophrenia and major depressive disorder), using genetic association, linkage and resequencing methodologies. In collaboration with Dr. Alice Whittemore, we are also actively engaged in statistical methods testing and development for genetic research.

  • Joseph Levitt, MD, MS

    Joseph Levitt, MD, MS

    Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford University Medical Center

    Current Research and Scholarly Interests My research focuses on the physiolgogic and biomarker characteristics of early acute lung injury (ALI) prior to need for mechanical ventilation. While, to date no pharmacologic treatment has improved survival in ALI, following the paradigm of early goal directed therapy for severe sepsis, clinical benefit may derive from identifying patients and initiating treatment prior to the need for positive pressure ventilation (and therefore prior to meeting current study entry criteria).

  • Lee Levitt

    Lee Levitt

    Professor of Medicine (Hematology) at the Santa Clara Valley Medical Center, Emeritus

    Current Research and Scholarly Interests Low molecular-weight heparins Clinical trials with anti-thrombotics Clinical trials in patients with leukemia, breast cancer and myeloma Medical education.

  • Michael Levitt

    Michael Levitt

    Robert W. and Vivian K. Cahill Professor in Cancer Research in the School of Medicine and Professor, by courtesy, of Computer Science

    Current Research and Scholarly Interests Stanford Professor of Biophysics and Computational Biology, Cambridge PhD and DSc, 2013 Chemistry Nobel Laureate (complex systems), FRS & US National Academy member, I code well for my age.

  • Ronald Levy, MD

    Ronald Levy, MD

    Robert K. and Helen K. Summy Professor in the School of Medicine

    Current Research and Scholarly Interests Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.

  • Shoshana Levy

    Shoshana Levy

    Professor (Research) of Medicine (Oncology)

    Current Research and Scholarly Interests Our research focuses on the mechanism of action of tetraspanins, an evolutionary conserved, widely expressed multi-gene family. We study a prototype, CD81, a molecule implicated in the pathogenesis of two major human diseases: hepatitis C virus (HCV) and malaria.

  • David B. Lewis

    David B. Lewis

    Professor of Pediatrics (Immunology) at the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests My laboratory is focused on defining cellular and molecular mechanisms that limit T cell responses to vaccines and pathogens during normal early postnatal development and in cases of inherited genetic immunodeficiencies. We are also determinomg how these limitations in immunity can be overcome by using novel approaches for vaccine adjuvants for influenza vaccine and by using catalytically inactive Cas proteins for inducing endogenous gene expression.

  • Eldrin F. Lewis, MD, MPH

    Eldrin F. Lewis, MD, MPH

    Simon H Stertzer, M.D. Professor

    Bio Dr. Lewis is a board-certified, fellowship-trained specialist in cardiovascular medicine. He is the chief of the Division of Cardiovascular Medicine and a professor of cardiovascular medicine.

    Dr. Lewis is an esteemed clinician-scientist who specializes in the care of patients with advanced heart failure. He is an internationally recognized expert on heart failure, heart transplant, and quality of life for heart failure patients. He cares deeply about his patients as well as his colleagues, the hospital, and the School of Medicine. Dr. Lewis is committed to diversity and inclusion, as well as expanding Stanford clinical research initiatives.

    A fundamental principle of Dr. Lewis? practice is his belief that ?there is more to life than death,? that cardiovascular care should go beyond helping patients survive to also helping them enjoy the best possible quality of life.

    Dr. Lewis has deep expertise in conducting clinical trials examining diagnostic and therapeutic approaches to heart failure. He has done innovative work to create systems for incorporating quality of life measures for cardiovascular patients into electronic health records. This research has received support from the National Heart, Lung and Blood Institute and the National Institutes of Health.

    Much of his quality of life research has focused on patient-reported outcomes. Dr. Lewis emphasizes the importance of looking at how a disease, whether chronic or acute, impacts people?s ability to function and perform their activities of daily living. Strategies to improve patients? well-being focus not only on their physical symptoms but also on depression, anxiety, exercise capacity, and ability to function in daily living.

    Dr. Lewis? commitment to expanding clinical research initiatives will give patients more opportunities to participate in the clinical trials and access the latest care strategies that can translate into better outcomes. The goal is early access to the most advanced technology, pharmacology, and device therapy that can change outcomes for the better. He also envisions forming closer partnerships with community cardiologists and capitalizing further on Stanford?s proximity to and unique relationships with the digital technology leaders of Silicon Valley to enhance the use of digital technology for monitoring patients, optimizing treatment, and tracking outcomes.

    He has authored nearly 200 articles published in peer-reviewed journals including the New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, JAMA Cardiology, JAMA Internal Medicine, and many more. He is also on multiple editorial boards for cardiovascular journals and was an associate editor for Circulation?Heart Failure. In addition, he is an author of professional society clinical practice guidelines and scientific statements from both the American Heart Association (AHA) and the Food and Drug Administration.

    Dr. Lewis? honors for clinical care, scholarship, and research include the Joel Gordon Miller Award for community service and leadership from the University of Pennsylvania School of Medicine. He also was one of the first recipients of the Minority Faculty Development Award, which recognizes the research potential of young physicians. Dr. Lewis has received a grant from the Robert Wood Johnson Foundation to study the role of quality of life assessment in clinical decision making in patients with heart failure.

    He is a fellow of the American College of Cardiology and the National American Heart Association (AHA) Research Committee. In addition, Dr. Lewis was as a member of the AHA Founders Affiliate Board of Directors, chair of the Council on Clinical Cardiology, and research chair of the Association of Black Cardiologists. He also serves on scientific committees to review grants for the AHA and on the FDA Task Force for the Standardization of Definitions for Endpoint Events in Cardiovascular Trials.

  • Matthew Lewis, MD, MPH

    Matthew Lewis, MD, MPH

    Clinical Associate Professor, Dermatology

    Bio Dr. Lewis specializes in autoimmune connective tissue diseases, immunobullous diseases, and other inflammatory skin diseases including psoriasis and sarcoidosis. He completed medical school at The George Washington University School of Medicine and dermatology residency at The University of Rochester, where he was chief resident. He also completed a Master?s of Public Health at Johns Hopkins and a fellowship in autoimmune connective tissue diseases at Stanford University.

    He believes multidisciplinary and holistic care is key to treat patients with systemic inflammatory diseases. He holds a rheumatology-dermatology clinic with a rheumatologist, Dr. Janice Lin, as well as a dermatology-ophthalmology clinic with an ophthalmologist, Dr. Christopher Ta, and is the dermatologist for the sarcoidosis program, all with this primary goal of providing high quality, collaborative, patient-centered care.

  • Richard Lewis

    Richard Lewis

    Professor of Molecular and Cellular Physiology

    Current Research and Scholarly Interests We study molecular mechanisms of calcium signaling with a focus on store-operated CRAC channels and their essential roles in T cell development and function. Currently we aim to define the molecular mechanism for CRAC channel activation and the means by which calcium signal dynamics mediate specific activation of transcription factors and T-cell genes during development.

  • Gordon Li, MD

    Gordon Li, MD

    Professor of Neurosurgery and, by courtesy, of Neurology and of Otolaryngology - Head & Neck Surgery (OHNS) at the Stanford University Medical Center

    Current Research and Scholarly Interests 1.) My laboratory studies the biology of brain tumors with the goal of developing novel therapeutics for the treatment of malignant brain tumors and translating that research into clinical trials.
    2.) My clinical interests include improving surgical techniques for brain tumor surgery, immunotherapy for the treatment of glioblastoma, and novel uses for stereotactic radiosurgery.

  • Jin Billy Li

    Jin Billy Li

    Associate Professor of Genetics

    Current Research and Scholarly Interests The Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.

  • Lingyin Li

    Lingyin Li

    Assistant Professor of Biochemistry

    Bio Dr. Li is an assistant professor in the Biochemistry Department and ChEM-H Institute at Stanford since 2015. Her lab works on understanding biochemical mechanisms of innate immunity and harnessing it to treat cancer. She majored in chemistry at University of Science and Technology of China and graduated with a B. En in 2003. She then trained with Dr. Laura Kiessling, a pioneer in chemical biology, at University of Wisconsin-Madison and graduated with a Ph.D in chemistry in 2010. She obtained her postdoctoral training with Dr. Timothy Mitchison at Harvard Medical School, who introduced her to the field of chemical immunology.

  • Ron Li

    Ron Li

    Clinical Assistant Professor, Medicine

    Bio Ron Li is a Clinical Assistant Professor of Medicine in the Division of Hospital Medicine and Center for Biomedical Informatics Research at Stanford University School of Medicine. His academic interests focus on the "delivery science" of artificial intelligence in healthcare and how to design, implement, and evaluate AI enabled systems of care delivery. As the Medical Informatics Director for Artificial Intelligence Clinical Integration at Stanford Health Care, he also helps lead the integration efforts of clinical AI for the health system. He is also the medical director for the Stanford Emerging Apps Lab (SEAL), which builds novel digital apps for clinicians at Stanford Health Care.

    Ron's work spans across multiple disciplines, including clinical medicine, data science, digital health, information technology, design thinking, process improvement, and implementation science. Current areas of focus include using machine learning to improve advance care planning, care of clinically deteriorating patients, and the expansion of virtual care networks. He has consulted for various companies in the digital health and artificial intelligence space, and is leading work in AI and UXR in partnership with Google Health. He is an attending physician on the inpatient medicine teaching service at Stanford Hospital, and is a core faculty for the Stanford Clinical Informatics Fellowship.

  • Ruijiang Li

    Ruijiang Li

    Assistant Professor (Research) of Radiation Oncology (Radiation Physics)

    Current Research and Scholarly Interests My lab's research is focused on the development of imaging and molecular biomarkers to improve early detection, diagnosis, prognostication, and prediction of therapy response in cancer. Our ultimate goal is to translate these biomarkers into clinical practice to guide optimal management and therapeutic decisions for precision cancer medicine.

  • Yi Li, MD, PhD

    Yi Li, MD, PhD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    Bio Dr. Li is a board-certified, fellowship-trained neurologist and a clinical assistant professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine.

    She specializes in epilepsy care and research. She has dedicated her career to advancing our understanding of the mechanism, diagnosis, and treatment of epilepsy. In addition to her MD degree, she holds a PhD degree in neurology and neuroscience. She undertook PhD training to better understand epileptogenesis and to identify potential new treatments for refractory epilepsy patients.

    Dr. Li has conducted extensive research on the mechanism of epileptogenesis via a hippocampal neural stem cell pathway and on the dynamic changes of microRNA, genes, and proteins in temporal lobe epilepsy.

    She has received the Stanford Genetics and Genomics Certificate, which helped advance her knowledge of how genomic data can enhance patient management in clinical practice.

    Dr. Li has presented the findings of many aspects of her epilepsy research at meetings of the American Epilepsy Society, American Clinical Neurophysiology Society, American Academy of Neurology, American Neurological Association, and International Conference on Function (Psychogenic) Neurological Disorders.

    She has published numerous articles on a wide range of epilepsy-related topics, including precision medicine in women with epilepsy, pregnancy outcomes of refractory epilepsy patients, and differentiation of epileptic from non-epileptic seizures. Her work has appeared in Neurology Clinical Practice, Epilepsia,Gene, Molecular Neurobiology, Neuroscience, International Journal of Molecular Medicine and elsewhere.

    Among her honors, Dr. Li has earned recognition from the American Epilepsy Society and International League Against Epilepsy. She also won a safety and quality awards scholarship from the American Academy of Neurology. She is a member of the American Academy of Neurology and the American Epilepsy Society.

  • David Liang, MD, PhD

    David Liang, MD, PhD

    Professor of Medicine (Cardiovascular) at the Stanford University Medical Center, Emeritus

    Bio Stanford researchers are creating a micro-device that physicians could guide through the body to help diagnose and treat clogged arteries and other diseases. Tethered to the outside world by a thin wire, a tiny machine creeps through blood vessels, searching out deadly plaques and obliterating them with a zap of a laser. While a laser will come later, for now David Liang, MD, PhD, is focusing on a tiny eye that could give physicians an unprecedented view into blood vessels.

  • Charles Liao

    Charles Liao

    Clinical Assistant Professor, Medicine

    Current Research and Scholarly Interests Educational Curriculum: Working with Professional Interpreters

  • Joseph C. Liao

    Joseph C. Liao

    Associate Professor of Urology

    Current Research and Scholarly Interests My laboratory is engaged in translational research to develop new in vitro and in vivo diagnostic tools for diseases of the urinary tract based on micro- and nanotechnology. We are developing an integrated biosensor platform optimized for point-of-care urinary diagnostics, particularly for urinary tract infections and bladder cancer. We are also developing in vivo imaging tools for applications in image-guided surgery.

  • Ronglih Liao

    Ronglih Liao

    Professor of Medicine (Cardiovascular Medicine)

    Bio Dr. Liao is a Professor of Medicine and co-Director of Stanford Cardiac Amyloid Center. The major goal of her research program focuses on understanding the mechanisms that underlie the pathophysiology of heart failure and developing novel treatments to combat this process. Her laboratory has played an international leading role in the study of amyloid light chain (AL) cardiomyopathy, a rare and fatal form of cardiovascular disease. We have described the underlying pathophysiologic basis for amyloid cardiomyopathy and found that the circulating amyloidogenic light chain proteins that characterize this disease directly result in a specific cardiotoxic response. Consequently, our research work has redefined AL cardiomyopathy and has raised new treatment approaches. More recently, her research efforts have expanded to include transthyretin (ATTR) cardiac amyloidosis.

    In line with her goal of revealing novel therapeutic strategies for patients with cardiovascular disease, our efforts have also focused on characterizing and harnessing endogenous cardiac regenerative mechanisms. Her laboratory initially demonstrated the therapeutic potential of exogenous primitive muscle cells delivered to the injured heart. This work was among the earliest milestones in the field and served as the basis for an international trial of cell-based therapy. Subsequently, Liao lab identified and characterized a population of cardiac progenitor cells and its relationship and dynamic activity following cardiac injury in the adult heart. Her laboratory aims to reveal the molecular mechanisms regulating the endogenous regenerative capacity of the heart and to harness such repair mechanisms for the treatment of cardiovascular disease. Dr. Liao has lectured extensively on both amyloid cardiomyopathy and stem cell biology, and have maintained a history of independent NIH funding in these areas for more than two decades.

    Over the course of her academic career, she has taken the greatest pride in mentoring the next generation of scientists. Dr. Liao has had the privilege to supervise several dozen students, postdoctoral fellows, and junior faculty, many of whom have gone on to independent academic careers at the highest institutions. Her contribution to the advancement of scientific knowledge also includes lecturing at various university and academic institutions as well as at scores of conferences and symposia locally, nationally, and internationally.

  • Y. Joyce Liao, MD, PhD

    Y. Joyce Liao, MD, PhD

    Professor of Ophthalmology and of Neurology at the Stanford University Medical Center

    Current Research and Scholarly Interests Ischemic optic neuropathy
    Stem cell transplantation
    Optic neuropathy
    Optic neuritis
    Eye movement disorders
    Reading
    Parkinson's disease
    Multiple sclerosis

  • Yungting Liao

    Yungting Liao

    Clinical Associate Professor, Pediatrics

    Current Research and Scholarly Interests clinical informatics, quality improvement

  • Michaela Liedtke

    Michaela Liedtke

    Associate Professor of Medicine (Hematology) at the Stanford University Medical Center

    Current Research and Scholarly Interests 1) Design of phase I/II trials for the treatment of Multiple Myeloma and Amyloidosis

    2) Conduct of clinical trials to improve the treatment of patients with acute lymphoblastic leukemia (ALL)

    3) Outcomes research using clinical databases for patients with Multiple Myeloma and Amyloidosis

    4) Characterization of the molecular mechanism of MLL-induced acute leukemia

  • Geoffrey Lighthall

    Geoffrey Lighthall

    Professor of Anesthesiology, Perioperative and Pain Medicine (Adult MSD) at the Palo Alto Veterans Affairs Health Care System

    Current Research and Scholarly Interests Research Interests

    I1. Care of the critically ill outside of the ICU
    A. Development and evaluation of Medical Emergency Teams (aka. Rapid
    Response Teams)
    B. Detecting deterioration of non-ICU patients
    C. Cardiac arrest teams

    II. Training for patient care crises -- emphasis on use of patient simulation methods
    A. ICU team training
    B. Simulation in medical student ICU education
    C. Resuscitation skills for code blue and RRT responses

  • Michael Lim, M.D.

    Michael Lim, M.D.

    Professor of Neurosurgery and, by courtesy, of Radiation Oncology (Radiation Therapy) and of Medicine (Oncology)

    Bio Dr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia.

    Dr. Lim?s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia. During his time at Johns Hopkins, Dr. Lim built one of the largest brain tumor and trigeminal neuralgia practices and utilized the most advanced surgical technologies and techniques for his patients. As a passionate voice for patient experience, he has been recognized by his peers and patients for his integrity and compassionate care, including a Service Excellence Award from HealthNetwork Foundation.

    As a mentor, he has garnered numerous teaching awards, including being honored as an outstanding teacher by Johns Hopkins University School of Medicine. He is actively involved in shaping education for neurosurgery and oncology across the United States and around the world.

    Dr. Lim?s research interests focus on harnessing the immune system to fight cancer. His laboratory focuses on understanding mechanisms of immune evasion by cancer cells. He has successfully translated his findings from the laboratory to the clinics and has conducted and led several large national immunotherapy clinical trials for brain tumors.

    Dr. Lim?s bibliography contains well over 200 articles on topics such as immunotherapy for glioblastoma, long-term survival of glioma patients treated with stereotactic radiation, and treatment of neuropathic pain. His work has appeared in Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, Nature Immunology, and many more publications. He also has written 20 book chapters and monographs.

    Dr. Lim is a world leader in immunotherapy for brain tumors. In addition to being invited world-wide to give lectures and seminars, he has given platform presentations on the topics of immunotherapy for brain tumors, neurosurgical techniques and management of brain tumors at the American Society of Clinical Oncologists, American Academy of Neurological Surgeons, Radiological Society of North America, Annual Symposium on Brain and Spine Metastases, Congress of Neurological Surgeons, and other meetings. In addition, he has served as platform chairman of the CNS session at the American Society for Clinical Oncology conference.

    Dr. Lim is a member of the American Society for Clinical Oncology, Congress of Neurological Surgeons, American Association of Neurological Surgeons, and Society for Neuro-Oncology. Dr. Lim served as the program co-chair of the Society for Neuro-Oncology and CNS section of the American Society for Clinical Oncology. He also served on many executive committees, including the Executive Committee for the Joint Tumor Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

  • David Limsui

    David Limsui

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Bio Throughout my career I have been extensively involved in post-graduate medical education and training of residents and fellows. I served on the AGA Future Trends Committee tasked with reporting the future of gastroenterology training programs and have been admitted into the AGA Academy of Educators. I joined Stanford for the incredible opportunity to be part of a dynamic division with excellent and dedicated faculty where one can achieve their greatest potential. I share the honor and privilege of leading our fellowship program and in the joy of teaching such talented and inspiring fellows. Together we strive to provide the best educational experience for our fellows to become outstanding gastroenterologists and future leaders in academic medicine.
    My subspecialty areas of focus are inflammatory bowel disease and general gastroenterology.

  • Bryant Lin

    Bryant Lin

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests -Digital Health Application and Medical device design, prototyping, testing and clinical trials
    -Behavioral determinants of chronic disease
    -Novel diagnostic processes for medical mysteries
    -Asian Health

  • Charles C. Lin, MD

    Charles C. Lin, MD

    Clinical Associate Professor, Ophthalmology

    Current Research and Scholarly Interests Dr. Lin spearheads the Cornea Transplant Program at Stanford and his research interests include improving the success and safety of cutting edge surgeries such as ultra-thin DSAEK, DMEK, and DALK. He is actively researching surgical therapies for corneal edema and Fuchs' Dystrophy. He is among a handful of cornea specialists nationwide with extensive experience using intraoperative OCT imaging to perform cornea transplants.

  • Dana Lin, MD

    Dana Lin, MD

    Clinical Assistant Professor, Surgery - General Surgery

    Bio Dr. Lin is a fellowship-trained endocrine surgeon who specializes in surgery of the thyroid, parathyroid, and adrenal glands. After receiving her undergraduate degree from Stanford University, Dr. Lin pursued her medical and surgical training on the east coast, where she completed her residency in general surgery at Rutgers Robert Wood Johnson Medical School and fellowship in endocrine surgery at the Harvard-affiliated Massachusetts General Hospital.

    Dr. Lin's clinical practice focuses on the surgical management of benign and malignant thyroid conditions, hyperparathyroidism, adrenal tumors, as well as melanoma and advanced skin cancers. She is skilled in mini-incision, minimally invasive (laparoscopic), and remote access (scarless endoscopic) surgery as well as lymph node dissection for cancer. She currently serves as Director of the Parathyroid Center within the Endocrine Oncology Program at Stanford.

    Dr. Lin strives to deliver expert surgical care to patients with utmost humanism and compassion. She considers it a privilege and joy to be entrusted as one?s surgeon and is committed to ensuring the best clinical and cosmetic outcome for each of her patients. Dr. Lin welcomes patients at Stanford Cancer Center in Palo Alto as well as Stanford Health Care in Emeryville and Pleasanton (ValleyCare).

  • Janice Lin

    Janice Lin

    Clinical Assistant Professor, Medicine - Immunology & Rheumatology

    Bio Dr. Lin specializes in the diagnosis and treatment of rheumatologic conditions such as rheumatoid arthritis, lupus, myositis, gout, and seronegative spondyloarthropathies. She received additional training in autoimmune skin diseases and has a special clinical and research interest for psoriasis/psoriatic arthritis, dermatomyositis, cutaneous lupus/systemic lupus. She leads a combined rheumatology-dermatology clinic with Dr. Matthew Lewis in the dermatology department to take care patients collaboratively. Dr. Lin is a graduate of USSONAR (Ultrasound School of North American Rheumatologists) program and performs diagnostic musculoskeletal ultrasound evaluation and interventions. In addition to her clinical work, she leads the quality improvement effort for the division and her most recent projects are focused on patient-reported outcome in rheumatoid arthritis and vaccinations for patients in the rheumatology clinic.

  • Kathie S Lin

    Kathie S Lin

    Clinical Assistant Professor, Neurology & Neurological Sciences

    Bio Dr. Lin practices both Neuromuscular Medicine and Comprehensive Neurology in Emeryville and Palo Alto. She has a particular interest in the diagnosis and management of neuromuscular disease including neuromuscular junction disorders, motor neuron disease, and focal neuropathy. Additionally, she is interested in medical education and developing a practical framework for teaching neurology and neurophysiology to medical students and neurology residents.

    She earned her medical degree at the University of Pittsburgh School of Medicine where was awarded a Dean's Scholarship and the Dr. Tryphena Humphrey Student Award in Neurology. She completed neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston where she served as an administrative chief resident in her final year and was awarded the Michael Ronthal Resident Teaching Award. She then went on to complete her neuromuscular medicine fellowship at Stanford.

  • Michael Lin

    Michael Lin

    Associate Professor of Neurobiology, of Bioengineering and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly Interests Our lab applies biochemical and engineering principles to the development of protein-based tools for investigating biology in living animals. Topics of investigation include fluorescent protein-based voltage indicators, synthetic light-controllable proteins, bioluminescent reporters, and applications to studying animal models of disease.

  • Stacy Lin

    Stacy Lin

    Clinical Instructor, Psychiatry and Behavioral Sciences

    Bio Dr. Stacy Lin is a licensed psychologist in the Department of Psychiatry and Behavioral Sciences who provides culturally-informed psychotherapy for the treatment of emotion dysregulation, eating disorders, and trauma. Dr. Lin has specialized training in comprehensive Dialectical Behavior Therapy and Cognitive Behavioral Therapy. She is broadly interested in issues of diversity and inclusion in clinical, training, and professional settings. Her research has examined cultural factors affecting disordered eating and body image in racial/ethnic minorities.

  • Steven Lin

    Steven Lin

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Artificial intelligence in healthcare
    Primary care and population health
    Value added medical education

  • Steven Lindley

    Steven Lindley

    Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) at the Palo Alto Veteran's Affairs Health Care System

    Current Research and Scholarly Interests Maximizing the use of evidence-based practices and reducing unnecessary medical burden of psychiatric treatments for stress-related disorders.

  • Benjamin Lindquist

    Benjamin Lindquist

    Clinical Assistant Professor, Emergency Medicine

    Current Research and Scholarly Interests International emergency medicine development and education.

  • Bruce Ling

    Bruce Ling

    Assistant Professor (Research) of Surgery (Pediatric Surgery)

    Bio Clinical Focus
    ? Big data analytics for quality improvement and clinical effectiveness
    ? Disease biomarker discovery through multi-omics based analyses

    Academic Appointments
    ? Assistant Professor Surgery

    Professional Education
    ? B.S., Biochemistry, Fudan University, China (1990)
    ? M.A., Molecular and Developmental Biology, UCLA, US (1994)
    ? Ph.D., Biological Chemistry, UCLA, US (1996)
    ? Postdoctoral training, medicine/oncology/Computer science, Stanford University, US (1996-1998)
    ? Business administration, Leavey School of Business, Santa Clara University, US (2000-2001)

  • Evelyn Bin Ling

    Evelyn Bin Ling

    Clinical Assistant Professor, Medicine

    Bio Evelyn Ling, M.D., M.S. is a Clinical Instructor at Stanford School of Medicine. She completed her M.D. degree and her internal medicine residency at the University of California at Davis in 2017. Prior to her medical training, she received her B.S. in biomedical computation and M.S. in Management Science and Engineering from Stanford University. In medical school and residency, she worked on projects in quality improvement (medication reconciliation in the hospital setting), medical education (clinical reasoning development) and health care technology (remote diabetes management). At ValleyCare, she has continues to be involved in medical education as the site co-director for Practice of Medicine course (POM) for second year physician assistant students as well as quality improvement projects in ED admissions and wellness. She is a Bay Area native and is excited to be working with the East Bay community.

  • Michael Link

    Michael Link

    Lydia J. Lee Professor in Pediatric Cancer

    Current Research and Scholarly Interests Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease.

  • Eleni Linos, MD, MPH, DrPH

    Eleni Linos, MD, MPH, DrPH

    Professor of Dermatology and, by courtesy, of Epidemiology and Population Health at the Stanford University Medical Center

    Bio Eleni Linos MD, MPH, DrPH, is Professor of Dermatology and Epidemiology at Stanford University.

    Her current work is focused on understanding the impact of novel coronavirus COVID-19 on the health and wellbeing of communities.

    Dr. Linos' work also focuses on public health, cancer prevention and the care of older adults. Dr. Linos is dually trained in epidemiology and dermatology and is the principal investigator of several NIH funded studies aimed at improving the lives of patients. She received her medical degree from Cambridge and Oxford universities in the UK, then trained in epidemiology at the Harvard School of Public Health and completed her residency at Stanford.

  • Douglas Liou

    Douglas Liou

    Clinical Assistant Professor, Cardiothoracic Surgery

    Bio Dr. Liou is a local product, having grown up in Salinas and graduated from U.C. Berkley with a degree in Molecular and Cell Biology. He received his M.D. from New York Medical College and completed his General Surgery training at Cedars-Sinai Medical Center in Los Angeles. At Cedars, he was recognized for his excellence in clinical care and research with numerous awards and publications. Dr. Liou recently completed his 2 years of Thoracic Surgery training at Stanford, during which time he proved to be an outstanding physician and surgeon and a dedicated clinical researcher.

    Dr. Liou?s expertise includes all surgical diseases of the lung, mediastinum, esophagus, chest wall, and diaphragm, with particular interest in thoracic oncology and minimally invasive surgical techniques. He has extensive experience with minimally invasive and open management of lung and esophageal cancer, mediastinal tumors, and benign esophageal disease. Dr. Liou's primary research focus has been on clinical outcomes in thoracic oncology and quality improvement.

    Dr. Liou practices out of Stanford Hospital main campus and Stanford Health Care-ValleyCare Hospital in Pleasanton, where he is starting Stanford's Thoracic Surgery program in the East Bay.

  • Grant Lipman

    Grant Lipman

    Clinical Professor, Emergency Medicine

    Current Research and Scholarly Interests Acute mountain sickness, exercise-associated hyponatremia,exercise-induced hyperthermia, hypothermia and hyperthermia, randomized controlled trials, examinations of novel biomedical devices, and big data, for prevention and treatment of environmental illnesses and injuries.

  • Joseph (Joe) Lipsick

    Joseph (Joe) Lipsick

    Professor of Pathology, of Genetics and, by courtesy, of Biology

    Current Research and Scholarly Interests Function and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.

  • Jafi Alyssa Lipson

    Jafi Alyssa Lipson

    Clinical Associate Professor, Radiology

    Current Research and Scholarly Interests Dr. Lipson's research interests include breast density and breast cancer risk assessment; informatics applications in breast imaging; early breast cancer detection and extent of disease evaluation using contrast enhanced mammography, digital breast tomosynthesis, and high resolution breast MRI; novel blood and imaging biomarkers of breast cancer burden and neoadjuvant treatment response; and image-guided wireless localization techniques for breast surgery.

  • Babak Litkouhi

    Babak Litkouhi

    Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology

    Bio Dr. Litkouhi joined the Stanford Women's Cancer Center in 2019. He was previously faculty at Yale and Harvard universities, and co-chief of gynecologic oncology at John Theurer Cancer Center in Hackensack, NJ. His expertise is in gynecologic surgery and medical and surgical management of gynecologic cancers. He is the program director of the gynecologic oncology fellowship program at Stanford. He has been the recipient of numerous patient-care and teaching awards.

  • Iris Litt

    Iris Litt

    Marron and Mary Elizabeth Kendrick Professor in Pediatrics, Emerita

    Current Research and Scholarly Interests Research focus is on the health problems of adolescent women, with particular emphasis on the interaction of psychosocial phenomena with biologic features of the second decade of life. The effects of eating disorders on reproductive physiology, bone density and growth is one example of this interest. Pregnancy prevention and medication compliance in adolescents are other research interests.

  • Anne Liu

    Anne Liu

    Clinical Associate Professor, Pediatrics - Immunology and Allergy

    Bio Dr. Liu is a board-certified, fellowship-trained specialist in allergy/immunology and infectious disease. She is also a clinical associate professor in the Department of Medicine, Division of Infectious Diseases and the Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology at Stanford University School of Medicine.

    Dr. Liu treats infections in patients with compromised immune systems, whether due to a primary immune deficiency or a condition like cancer or organ transplant. She helps patients to develop tolerance to medications they are allergic to so that they can receive the best, and sometimes the only, treatments available to them. She also treats allergies to antibiotics, aspirin, NSAIDs, chemotherapy, and more. She sees patients both long term and for urgent referrals, such as in cases of perioperative anaphylaxis. Dr. Liu also helps pediatric patients manage drug and food allergies.

    One of Dr. Liu?s areas of focus is helping patients with allergies to antibiotics determine when they have lost an allergy, what antibiotics they can tolerate, and when to induce tolerance to an antibiotic. This not only can benefit the patient, but also have a positive public health impact, as labeling patients with a penicillin allergy may negatively affect their care and increase use
    of broad-spectrum antibiotics.

    She collaborates closely with colleagues from other disciplines, including pulmonology, otolaryngology, oncology, cardiology, dermatology, anesthesiology, and surgery. Her key objective in working with referring physicians is to help them safely deliver the best care for their patients.

    For patients and families, Dr. Liu strives to help them navigate their care journey with as much ease and dignity as possible during what may be the most challenging time of their life. Her goal is to offer patients options, even when it may appear that they have no options left.

    Dr. Liu?s research interests include optimizing care of patients with antibiotic allergies, including through use of decision support tools.

    Dr. Liu has authored articles in the New England Journal of Medicine, Journal of Immunology, Journal of Allergy and Clinical Immunology in Practice, Clinical and Experimental Allergy, Mucosal Immunology, Diagnostic Microbiology and Infectious Disease, Science, and other publications. Dr. Liu authored the book chapter ?Hypersensitivity Reactions to Monoclonal Antibodies? in Drug Allergy Testing.

    Dr. Liu is certified in infectious disease by the American Board of Internal Medicine and in allergy and immunology by the American Board of Allergy and Immunology. She is also a member of the American College of Physicians, Infectious Diseases Society of America, and American Academy of Allergy, Asthma, and Immunology.

    She has given presentations on antibiotic allergies, drug desensitization, and aspirin-exacerbated respiratory disease, among other topics. Dr. Liu?s honors include recognition from the American Academy of Asthma, Allergy, and Immunology, the American Medical Women?s Association, and the National Institutes of Health.

  • Christine Kee Liu

    Christine Kee Liu

    Assistant Professor of Medicine (Primary Care and Population Health) at the Stanford University Medical Center

    Bio Dr. Liu and her research program are dedicated to improving the lives of older adults with kidney disease. Currently her research focuses on mobility, which is the ability to move safely and reliably from one place to another. In older adults, poor mobility strongly predicts future disability and death. Retaining mobility has been cited by older adults as fundamental to quality to life; yet many older persons with kidney disease, especially those with late stage chronic kidney disease or outright kidney failure, have trouble just walking across the room or transferring to a chair. Dually trained in geriatric medicine and epidemiology, Dr. Liu also has significant expertise in older adult clinical trials, including safety trials of novel agents as well as intervention studies to reduce infections in older populations.

  • Stanley Yung Liu, MD, DDS, FACS

    Stanley Yung Liu, MD, DDS, FACS

    Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Surgery (Plastic and Reconstructive Surgery) at the Stanford University Medical Center

    Bio Dr. Liu is as an Assistant Professor of Otolaryngology, and by courtesy, of Plastic and Reconstructive Surgery at Stanford University School of Medicine. He is director of the Stanford Sleep Surgery Fellowship, and preceptor to the Stanford Oculoplastic Surgery Fellowship. He is a Stanford Biodesign Faculty Fellow Alumnus.

    After graduating from Stanford University with a degree in Biology, Dr. Liu received medical and dental degrees from the University of California-San Francisco (UCSF). He was a former Howard Hughes Medical Institute (HHMI) Research Scholar and spent a year at the NIH. After oral and maxillofacial surgery residency at UCSF, he completed the Stanford sleep surgery fellowship in 2014 with the Department of Otolaryngology and sleep surgery pioneer Dr. Robert Riley.

    Dr. Liu practices the full scope of sleep apnea surgery including nasal, palate, tongue base, hypoglossal nerve stimulation, genioglossus advancement, and maxillomandibular advancement (MMA). He introduced adult maxillary expansion (DOME) for OSA with Professor Christian Guilleminault in 2015, and has continued to update the comprehensive sleep surgery protocol at Stanford.

    He is also routinely referred patients who need complex facial trauma reconstruction and orthognathic surgery.

    Dr. Liu's active areas of research include dynamic airway examination to optimize sleep surgery outcome, virtual surgical planning for facial skeletal surgery, and neuromodulation of the upper airway. He has given keynote talks nationally and internationally at preeminent conferences across specialties. He has published over 90 scientific articles and medical texts, with original scientific work on sleep surgery.

  • Wu Liu

    Wu Liu

    Associate Professor of Radiation Oncology (Radiation Physics) at the Stanford University Medical Center

    Current Research and Scholarly Interests Theranostic nanoparticles for radiosensitization and medical imaging. Novel treatment technique for ocular disease radiotherapy. Use artificial intelligence in image guided radiotherapy and medical image analysis. Ultrasound parametric imaging.

  • Anthony Lo

    Anthony Lo

    Clinical Instructor, Radiation Oncology - Radiation Physics

    Current Research and Scholarly Interests Image guided robotic radiosurgery

  • Clara Lo

    Clara Lo

    Clinical Associate Professor, Pediatrics - Hematology & Oncology

    Current Research and Scholarly Interests Research interests include:
    Biomarkers and targeted therapy in pediatric immune thrombocytopenia
    Transfusion-related iron overload
    Hemophilia and other rare bleeding disorders
    Thrombophilia

Footer Links:

Stanford Medicine Resources: